Australia Set To Decide On Breast Implant Cancer Link; Dutch Say No To A Ban
Executive Summary
Australian regulators expect to say in a few weeks’ time what action, if any, they will take on breast implants following the ongoing worldwide reports of a link between certain types of product and a rare form of cancer. Meanwhile, authorities in the Netherlands say the implants can stay on the market.
You may also be interested in...
Breast Implant-Makers Now Required To File Individual Reports On Each Adverse Event, FDA Says
The agency is redoubling efforts to warn women about the risks of silicone and saline breast implants after feedback from a recent advisory panel meeting. On 2 May, the regulator said it is requiring manufacturers to file individual Medical Device Reports for each adverse event regarding implants – part of a bigger effort to end its Alternative Summary Reporting Program for all devices.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.